Study of Oral Palifosfamide Tris in Solid Tumors
The study of maximum tolerated dose and safety of oral palifosfamide tris capsules in advanced, refractory, solid tumors
Advanced Cancer
DRUG: oral palifosfamide tris
Toxicities, 9 months
Safety, 9 months
The study of maximum tolerated dose and safety of oral palifosfamide tris capsules in advanced, refractory, solid tumors